Antithrombotic Strategy After Transcatheter Aortic Valve Replacement: A Network Meta-Analysis

Current Problems in Cardiology - Tập 47 - Trang 101348 - 2022
Gauranga Mahalwar1, Ashish Kumar1, Monil Majmundar2, Olayinka Adebolu1, Revanth Yendamuri1, Nicole Lao1, Nishad Barve1, Rolf P. Kreutz3, Grant W. Reed4, Rishi Puri4, Sourbha S. Dani5, Ankur Kalra6
1Department of Medicine, Cleveland Clinic Akron General, Akron, Ohio, United States
2Department of Cardiovascular Medicine, Maimonides Medical Center, NY, New York
3Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University School of Medicine, Indianapolis, IN
4Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH
5Department of Cardiovascular Medicine, Lahey Hospital & Medical Center, Burlington, MA
6Division of Cardiology, Department of Medicine, Cardiovascular Institute, Kalra Hospitals, New Delhi, India

Tài liệu tham khảo

Carroll, 2020, STS-ACC TVT Registry of transcatheter aortic valve replacement, J Am Coll Cardiol, 76, 2492, 10.1016/j.jacc.2020.09.595 Ommen, 2020, 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the AMERICAN college of cardiology/AMERICAN heart association joint committee on clinical practice guidelines, J Am Coll Cardiol., 76, 3022, 10.1016/j.jacc.2020.08.044 Greco, 2020, Anticoagulation after transcatheter aortic valve implantation: current status, Interv Cardiol (London, England), 15 Capodanno, 2019, Tailoring antiplatelet therapy in patients undergoing transcatheter aortic valve replacement: navigating the unknown∗, JACC Cardiovasc Interv, 12, 33, 10.1016/j.jcin.2018.10.047 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, PLoS Med, 6, 10.1371/journal.pmed.1000097 Dangas, 2019, A controlled trial of rivaroxaban after transcatheter aortic-valve replacement, N Engl J Med, 382, 120, 10.1056/NEJMoa1911425 Rogers, 2021, Randomized trial of aspirin versus warfarin after transcatheter aortic valve replacement in low-risk patients, Circ Cardiovasc Interv, 14, 10.1161/CIRCINTERVENTIONS.120.009983 Brouwer, 2020, Aspirin with or without clopidogrel after transcatheter aortic-valve implantation, N Engl J Med, 383, 1447, 10.1056/NEJMoa2017815 Rodés-Cabau, 2017, Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomi, JACC Cardiovasc Interv, 10, 1357, 10.1016/j.jcin.2017.04.014 Stabile, 2014, SAT-TAVI (single antiplatelet therapy for TAVI) study: A pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation, Int J Cardiol, 174, 624, 10.1016/j.ijcard.2014.04.170 Ussia, 2011, Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation, Am J Cardiol, 108, 1772, 10.1016/j.amjcard.2011.07.049 Collet, 2018, Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial, Am Heart J, 200, 44, 10.1016/j.ahj.2018.03.008 Nijenhuis, 2020, Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation, N Engl J Med, 382, 1696, 10.1056/NEJMoa1915152 Van Mieghem, 2021, Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR, N Engl J Med, 385, 2150, 10.1056/NEJMoa2111016 Greco, 2019, Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update, Expert Rev Cardiovasc Ther, 17, 479, 10.1080/14779072.2019.1632189 Capodanno, 2019, Stroke after transcatheter aortic valve replacement: a multifactorial phenomenon, JACC Cardiovasc Interv, 12, 1590, 10.1016/j.jcin.2019.07.004 Ranasinghe, 2019, Thromboembolic and bleeding complications in transcatheter aortic valve implantation: insights on mechanisms, prophylaxis and therapy, J Clin Med, 8, 280, 10.3390/jcm8020280 Mitrosz, 2017, Thrombocytopenia associated with TAVI—The summary of possible causes, Adv Med Sci, 62, 378, 10.1016/j.advms.2017.04.003 Gawaz, 2004, Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium, Cardiovasc Res, 61, 498, 10.1016/j.cardiores.2003.11.036 Wilkerson, 2002, Aging and thrombosis, Semin Thromb Hemost, 28, 555, 10.1055/s-2002-36700 Yanagisawa, 2019, Early and late leaflet thrombosis after transcatheter aortic valve replacement, Circ Cardiovasc Interv, 12, 10.1161/CIRCINTERVENTIONS.118.007349 Midha, 2017, The fluid mechanics of transcatheter heart valve leaflet thrombosis in the neosinus, Circulation, 136, 1598, 10.1161/CIRCULATIONAHA.117.029479 Rodés-Cabau, 2013, Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events, J Am Coll Cardiol, 62, 2349, 10.1016/j.jacc.2013.03.029 Nombela-Franco, 2012, Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation, Circulation, 126, 3041, 10.1161/CIRCULATIONAHA.112.110981 Guedeney, 2019, Antithrombotic therapy after transcatheter aortic valve replacement, Circ Cardiovasc Interv, 12, 10.1161/CIRCINTERVENTIONS.118.007411 Kalra, 2021, Off-label use of direct oral anticoagulants in patients receiving surgical mechanical and bioprosthetic heart valves, JAMA Netw Open, 4, 10.1001/jamanetworkopen.2021.1259 De Backer, 2019, Reduced leaflet motion after transcatheter aortic-valve replacement, N Engl J Med, 382, 130, 10.1056/NEJMoa1911426